Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)

BACKGROUND: Prostate cancer (PCa) is one of the most diagnosed cancers in the world. PCa inevitably progresses to castration-resistant prostate cancer (CRPC) after androgen deprivation therapy treatment, and castration-resistant state means a shorter survival time than other causes. Here we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Shi, Hui, Zhao, Zhenjun, Xu, Minghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580185/
https://www.ncbi.nlm.nih.gov/pubmed/36258196
http://dx.doi.org/10.1186/s12894-022-01113-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580185/
https://www.ncbi.nlm.nih.gov/pubmed/36258196
http://dx.doi.org/10.1186/s12894-022-01113-5

Ejemplares similares